{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:36:16Z","timestamp":1761514576811,"version":"3.41.2"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chagas disease, caused by the parasite Trypanosoma cruzi, once considered a disease confined to Mexico, Central America, and South America, is now an emerging global public health problem. An estimated 300 000 immigrants in the United States are chronically infected with T. cruzi. However, awareness of Chagas disease among the medical community in the United States is poor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We review our experience managing 60 patients with Chagas disease in hospitals throughout the New York City metropolitan area and describe screening, clinical manifestations, EKG findings, imaging, and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The most common country of origin of our patients was El Salvador (n = 24, 40%), and the most common detection method was by routine blood donor screening (n = 21, 35%). Nearly half of the patients were asymptomatic (n = 29, 48%). Twenty-seven patients were treated with either benznidazole or nifurtimox, of whom 7 did not complete therapy due to side effects or were lost to follow-up. Ten patients had advanced heart failure requiring device implantation or organ transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Based on our experience, we recommend that targeted screening be used to identify at-risk, asymptomatic patients before progression to clinical disease. Evaluation should include an electrocardiogram, echocardiogram, and chest x-ray, as well as gastrointestinal imaging if relevant symptoms are present. Patients should be treated if appropriate, but providers should be aware of adverse effects that may prevent patients from completing treatment.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofaa156","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T03:25:53Z","timestamp":1588821953000},"source":"Crossref","is-referenced-by-count":12,"title":["Chagas Disease in the New York City Metropolitan Area"],"prefix":"10.1093","volume":"7","author":[{"given":"Crystal","family":"Zheng","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, Louisiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Quintero","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K","family":"Revere","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell University, Manhasset, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B","family":"Oey","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell University, Manhasset, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Espinoza","sequence":"first","affiliation":[{"name":"Metro Infectious Diseases Consultants, Burr Ridge, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram A","family":"Puius","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ramirez-Baron","sequence":"first","affiliation":[{"name":"Grameen VidaSana Clinic, Queens, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R","family":"Salama","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Elmhurst Hospital Center-Icahn School of Medicine at the Mount Sinai Hospital, Queens, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F","family":"Hidalgo","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana S","family":"Machado","sequence":"first","affiliation":[{"name":"Federal University of Minas Gerais, Belo Horizonte, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Saeed","sequence":"first","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jooyoung","family":"Shin","sequence":"first","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snehal R","family":"Patel","sequence":"first","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M","family":"Coyle","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Albert Einstein College of Medicine and Jacobi Medical Center, Bronx, New York, USA"},{"name":"Division of Parasitology, Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert B","family":"Tanowitz","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Albert Einstein College of Medicine and Jacobi Medical Center, Bronx, New York, USA"},{"name":"Division of Parasitology, Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"author":"World Health Organization","key":"2020053002195971200_CIT0001"},{"key":"2020053002195971200_CIT0002","first-page":"334","article-title":"Chagas disease (American trypanosomiasis) fact sheet (revised in June 2010)","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"2020053002195971200_CIT0003","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"2020053002195971200_CIT0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actatropica.2018.04.008","article-title":"What makes an effective Chagas disease vector? Factors underlying Trypanosoma cruzi-triatomine interactions","volume":"183","author":"de Fuentes-Vicente","year":"2018","journal-title":"Acta Trop"},{"key":"2020053002195971200_CIT0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/cir956","article-title":"Oral transmission of Chagas disease","volume":"54","author":"Shikanai-Yasuda","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pcad.2009.02.001","article-title":"Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease)","volume":"51","author":"Tanowitz","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"2020053002195971200_CIT0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-385863-4.00002-2","article-title":"Acute and congenital Chagas disease","volume":"75","author":"Bern","year":"2011","journal-title":"Adv Parasitol"},{"key":"2020053002195971200_CIT0008","first-page":"141","article-title":"Blood donor screening for chagas disease\u2014United States, 2006\u20132007","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020053002195971200_CIT0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas disease in Europe: a review for the internist in the globalized world","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2020053002195971200_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385863-4.00001-0","article-title":"Epidemiology of American trypanosomiasis (Chagas disease)","volume":"75","author":"Kirchhoff","year":"2011","journal-title":"Adv Parasitol"},{"key":"2020053002195971200_CIT0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"2020053002195971200_CIT0012","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1572-0241.1998.270_r.x","article-title":"Gastrointestinal manifestations of Chagas\u2019 disease","volume":"93","author":"de Oliveira","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"2020053002195971200_CIT0013","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1128\/CMR.00023-19","article-title":"Chagas disease in the United States: a public health approach","volume":"33","author":"Bern","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2020053002195971200_CIT0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12879-018-3118-5","article-title":"Serological evaluation for Chagas disease in migrants from Latin American countries","volume":"18","author":"Pane","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2020053002195971200_CIT0015","doi-asserted-by":"crossref","first-page":"e01217","DOI":"10.1128\/JCM.01217-19","article-title":"Chagas disease serological test performance in U.S. blood donor specimens","volume":"57","author":"Whitman","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2020053002195971200_CIT0016","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1371\/journal.pntd.0001881","article-title":"A systematic review of high quality diagnostic tests for Chagas disease","volume":"6","author":"Afonso","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2020053002195971200_CIT0017","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N Engl J Med"},{"key":"2020053002195971200_CIT0018","doi-asserted-by":"crossref","first-page":"e13279","DOI":"10.1111\/ctr.13279","article-title":"Heart transplant outcomes in patients with Chagas cardiomyopathy in the United States","volume":"32","author":"Benatti","year":"2018","journal-title":"Clin Transplant"},{"key":"2020053002195971200_CIT0019","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1371\/journal.pntd.0001136","article-title":"Chagas disease has now gone global","volume":"5","author":"Tanowitz","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2020053002195971200_CIT0020","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/605091","article-title":"An estimate of the burden of Chagas disease in the United States","volume":"49","author":"Bern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0021","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/cid\/cix064","article-title":"Prevalence of Chagas disease in the Latin American-born population of Los Angeles","volume":"64","author":"Meymandi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0022","first-page":"256","article-title":"Determination of the sensitivity and specificity of three serodiagnostic assays for Chagas disease by latent class analysis [abstract]","volume":"85","author":"Cassandra","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"2020053002195971200_CIT0023","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1128\/JCM.34.9.2143-2147.1996","article-title":"Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas\u2019 disease","volume":"34","author":"Umezawa","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2020053002195971200_CIT0024","doi-asserted-by":"crossref","first-page":"e1689","DOI":"10.1371\/journal.pntd.0001689","article-title":"Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach","volume":"6","author":"Qvarnstrom","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2020053002195971200_CIT0025","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","article-title":"Evaluation and treatment of Chagas disease in the United States: a systematic review","volume":"298","author":"Bern","year":"2007","journal-title":"JAMA"},{"key":"2020053002195971200_CIT0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/0037-8682-0505-2016","article-title":"2nd Brazilian consensus on Chagas disease","volume":"49(","author":"Dias","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"2020053002195971200_CIT0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40506-018-0170-z","article-title":"Treatment of Chagas disease in the United States","volume":"10","author":"Meymandi","year":"2018","journal-title":"Curr Treat Options Infect Dis"},{"key":"2020053002195971200_CIT0028","doi-asserted-by":"crossref","first-page":"803","DOI":"10.15585\/mmwr.mm6729a3","article-title":"Characteristics of patients for whom benznidazole was released through the CDC-sponsored investigational new drug program for treatment of Chagas disease - United States, 2011-2018","volume":"67","author":"Herwaldt","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020053002195971200_CIT0029","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1469-0691.12443","article-title":"Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile","volume":"20","author":"Salvador","year":"2014","journal-title":"Clin Microbiol Infect"},{"year":"2013","author":"City of New York Department of City Planning","key":"2020053002195971200_CIT0030"},{"year":"2018","author":"Mayor\u2019s Office of Immigrant Affairs","key":"2020053002195971200_CIT0031"},{"key":"2020053002195971200_CIT0032","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2015\/628981","article-title":"A family cluster of Chagas disease detected through selective screening of blood donors: a case report and brief review","volume":"26","author":"Mongeau-Martin","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2020053002195971200_CIT0033","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/cid\/ciz087","article-title":"Prevalence of Chagas disease among family members of previously diagnosed patients in Los Angeles, California","volume":"69","author":"Hernandez","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0034","doi-asserted-by":"crossref","first-page":"e1959","DOI":"10.1371\/journal.pntd.0001959","article-title":"The epidemiological relevance of family study in Chagas disease","volume":"7","author":"Zulantay","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2020053002195971200_CIT0035","doi-asserted-by":"crossref","first-page":"e0157597","DOI":"10.1371\/journal.pone.0157597","article-title":"Chagas cardiomyopathy: usefulness of EKG and echocardiogram in a non-endemic country","volume":"11","author":"S\u00e1nchez-Montalv\u00e1","year":"2016","journal-title":"PLoS One"},{"key":"2020053002195971200_CIT0036","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gastrohep.2009.07.009","article-title":"Diagnosis, management and treatment of chronic Chagas\u2019 gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic","volume":"33","author":"Pinazo","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"2020053002195971200_CIT0037","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/AAC.00537-10","article-title":"Tolerance of benznidazole in treatment of Chagas\u2019 disease in adults","volume":"54","author":"Pinazo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2020053002195971200_CIT0038","doi-asserted-by":"crossref","first-page":"e0185033","DOI":"10.1371\/journal.pone.0185033","article-title":"Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease","volume":"12","author":"Olivera","year":"2017","journal-title":"PLoS One"},{"key":"2020053002195971200_CIT0039","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/civ005","article-title":"Tolerance of benznidazole in a United States Chagas disease clinic","volume":"60","author":"Miller","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0040","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0041","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/ciw477","article-title":"Safety profile of nifurtimox for treatment of Chagas disease in the United States","volume":"63","author":"Forsyth","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0042","doi-asserted-by":"crossref","first-page":"e12996","DOI":"10.1111\/tid.12996","article-title":"Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016","volume":"20","author":"Gray","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2020053002195971200_CIT0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0000000000002019","article-title":"Chagas disease recommendations for solid-organ transplant recipients and donors","volume":"102(2S Suppl 2)","author":"Pierrotti","year":"2018","journal-title":"Transplantation"},{"key":"2020053002195971200_CIT0044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trre.2010.12.002","article-title":"Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas","volume":"25","author":"Pinazo","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"2020053002195971200_CIT0045","doi-asserted-by":"crossref","first-page":"e13546","DOI":"10.1111\/ctr.13546","article-title":"Infectious Diseases Community of Practice of the American Society of Transplantation. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients\u2014Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"La Hoz RM, Morris M","year":"2019","journal-title":"Clin Transplant"},{"key":"2020053002195971200_CIT0046","first-page":"210","article-title":"Chagas disease after organ transplantation\u2014United States, 2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020053002195971200_CIT0047","first-page":"798","article-title":"Chagas disease after organ transplantation\u2014Los Angeles, California, 2006","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020053002195971200_CIT0048","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/598931","article-title":"Transmission of Trypanosoma cruzi by heart transplantation","volume":"48","author":"Kun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020053002195971200_CIT0049","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4269\/ajtmh.17-0691","article-title":"\u201cIt\u2019s like a phantom disease\u201d: patient perspectives on access to treatment for Chagas disease in the United States","volume":"98","author":"Forsyth","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020053002195971200_CIT0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3201\/eid1605.091440","article-title":"Physician awareness of Chagas disease, USA","volume":"16","author":"Stimpert","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"2020053002195971200_CIT0051","doi-asserted-by":"crossref","first-page":"e1771","DOI":"10.1371\/journal.pntd.0001771","article-title":"Seroprevalence of Chagas infection in the donor population","volume":"6","author":"Zaniello","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa156\/33179092\/ofaa156.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/5\/ofaa156\/33324630\/ofaa156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/5\/ofaa156\/33324630\/ofaa156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T19:31:15Z","timestamp":1696102275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa156\/5831335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa156","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,5,1]]},"article-number":"ofaa156"}}